{"entities": {"annotations": [{"start": 47, "end": 58, "probability": 0.9148, "type": "Place", "normalized_text": "SOUTH AFRICA"}, {"start": 62, "end": 67, "probability": 0.7987, "type": "Place", "normalized_text": "AFRICA"}, {"start": 78, "end": 93, "probability": 0.3211, "type": "Organization", "normalized_text": "Wits University"}, {"start": 217, "end": 239, "probability": 0.6229, "type": "Organization", "normalized_text": "Oxford Jenner Institute"}], "mentions": [{"start": 201, "end": 213, "username": "UniofOxford", "id": "48289662"}], "urls": [{"start": 262, "end": 285, "url": "https://t.co/w8T37cJZdq", "expanded_url": "http://www.wits.ac.za/covid19vaccine/", "display_url": "wits.ac.za/covid19vaccine/"}, {"start": 286, "end": 309, "url": "https://t.co/xrmjm0tq3k", "expanded_url": "https://twitter.com/WitsUniversity/status/1275358056054960132/photo/1", "display_url": "pic.twitter.com/xrmjm0tq3k"}], "hashtags": [{"start": 1, "end": 11, "tag": "VIDACov19"}]}, "text": "\ud83d\udc89#VIDACov19 : FIRST COVID-19 VACCINE TRIAL IN SOUTH AFRICA &amp; AFRICA BEGINS. \n\nWits University is hosting a virtual press conference for the Ox1Cov-19 Vaccine VIDA-Trial. Wits is collaborating with @UniofOxford &amp; the Oxford Jenner Institute on the trial: https://t.co/w8T37cJZdq https://t.co/xrmjm0tq3k", "public_metrics": {"retweet_count": 788, "reply_count": 231, "like_count": 1610, "quote_count": 229}, "lang": "en", "conversation_id": "1275358056054960132", "context_annotations": [{"domain": {"id": "123", "name": "Ongoing News Story", "description": "Ongoing News Stories like 'Brexit'"}, "entity": {"id": "1220701888179359745", "name": "COVID-19"}}], "created_at": "2020-06-23T09:20:30.000Z", "id": "1275358056054960132", "attachments": {"media_keys": ["3_1275358044256448512"]}, "author_id": "58521645", "reply_settings": "everyone", "source": "Twitter Web App", "possibly_sensitive": false}